Quarterly report pursuant to Section 13 or 15(d)

(Loss) earnings per share - Narrative (Details)

v3.22.2.2
(Loss) earnings per share - Narrative (Details)
9 Months Ended
Sep. 30, 2021
shares
Earnings Per Share [Abstract]  
Antidilutive shares (in shares) 5,397,048